--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Moody's
MCO
Coca-Cola
KO
VeriSign
VRSN
MasterCard
MA
DaVita
DVA
US Stock MarketDetailed Quotes
NVCT Nuvectis Pharma
- 6.170
- -0.060-0.96%
Close Jan 8 16:00 ET
119.21MMarket Cap-5.32P/E (TTM)
6.388High5.900Low79.19KVolume6.280Open6.230Pre Close485.61KTurnover1.21%Turnover RatioLossP/E (Static)19.32MShares12.10052wk High10.84P/B40.46MFloat Cap4.44052wk Low--Dividend TTM6.56MShs Float20.920Historical High--Div YieldTTM7.83%Amplitude3.080Historical Low6.132Avg Price1Lot Size
Nuvectis Pharma Key Stats
Nuvectis Pharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Nuvectis Pharma Earnings Reports
Read more
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Analysis
Price Target
No Data